Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Explore the best long term stocks to buy for sustained growth. Make wise investments that can pay off in the future.
27,330 articlesA boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Dividend stocks paused last week as Crown Castle and AT&T tumbled while Coca-Cola rose. The move highlights a cooling...
The Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
Rising capex threatens the cash-flow yields that power popular cash cows. This report explains why and what investors...
A quiet international fund is flashing some of the strongest gains in 2026. Schwab’s international ETF has climbed sh...
Robinhood Chain goes live on mainnet, delivering Layer 2 scalability for tokenized assets and a suite of around-the-c...
When markets wobble, the strength of a company’s balance sheet and its cash runway often beat a glossy business story...
A new Los Angeles exhibit invites you to look beyond the iconic white dress and pink gowns. This personal-finance fri...
A quiet, multi-year surge in AI infrastructure, defense modernization, and electrification is boosting a diversified ...
Investors have long looked to deals to jumpstart Netflix's growth. Five paraphrased lines from Netflix's co-CEO revea...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...